Papers

1

Total Citations

10

H-Index

1

About

Charles Leduc is a leading figure in biomedical optics, with a primary focus on the development of Raman spectroscopy for rapid, non-invasive cancer diagnostics. His most impactful work addresses a critical clinical bottleneck: the early and accurate detection of lung cancer, particularly in challenging peripheral lesions where conventional bronchoscopy often fails. Leduc’s landmark 2023 study, "Subsecond lung cancer detection within a heterogeneous background of normal and benign tissue using single-point Raman spectroscopy," demonstrates a revolutionary approach that achieves near-instantaneous tissue characterization with high specificity. This work, already garnering 10 citations, promises to dramatically improve diagnostic yield and reduce the need for invasive biopsies. By proving that Raman spectroscopy can distinguish malignant from benign tissue in a complex, heterogeneous background, Leduc has laid the groundwork for real-time, in vivo guidance during bronchoscopic procedures. His contributions are pivotal in the fight against lung cancer, the deadliest cancer in North America, offering a tangible path toward earlier intervention and improved patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Subsecond lung cancer detection within a heterogeneous background of normal and benign tissue using single-point Raman spectroscopy
10 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Centre Hospitalier de l’Université de Montréal

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago